Higher risk of postpartum depression in mothers with MS

Credibility

Interest

Key Takeaway

Mothers with multiple sclerosis (MS) were about twice as likely to need treatment for postpartum depression within a year after giving birth compared with mothers without MS.

What They Found

Researchers looked at every live birth in Denmark from 1997–2023 to see who filled prescriptions for antidepressants within 12 months after delivery. They used filling an antidepressant prescription as a sign of treatment-requiring postpartum depression (PPD). About 8.3% of births to mothers with MS led to antidepressant prescriptions versus 3.8% for mothers without MS. After accounting for factors like age, earlier antidepressant use, number of previous births, and whether the baby was born early or as twins, mothers with MS still had about 1.9 times the odds of needing antidepressants. The study suggests mothers with MS face a noticeably higher chance of needing treatment for PPD during the first year after birth.

Who Should Care and Why

Mothers with MS should pay attention because this study shows a higher likelihood of needing treatment for postpartum depression, so watching mood after birth is important. Caregivers and partners should be aware that symptoms like low mood, loss of interest, trouble sleeping, or feeling unable to cope may need earlier attention and can be more likely in someone with MS. Healthcare providers (neurologists, obstetricians, midwives, and mental health professionals) should consider closer monitoring and coordination of care around pregnancy and the year after birth. Think of it like increasing checks on a car that has a known issue: if MS raises the chance of PPD, more frequent mood check-ins can help catch problems early. This may change care routines by encouraging planned screening, easy routes to counseling or medication, and stronger support after delivery.

Important Considerations

The study used prescriptions for antidepressants as a sign of postpartum depression, but not everyone with PPD fills a prescription and some antidepressants are used for other conditions, so the number may not match all cases. The data come from Denmark, where health care and prescription practices may differ from other countries, so results might not be exactly the same elsewhere. The study shows an association (a link) but cannot prove MS causes PPD; other unmeasured factors could also play a role.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Mental Wellness Caregivers Living with MS

Article Topics:

Multiple Sclerosismaternalmental disorderspostpartum depressionpregnancy

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News